ATE217309T1 - Verbindungen des chinolizinon-typs - Google Patents
Verbindungen des chinolizinon-typsInfo
- Publication number
- ATE217309T1 ATE217309T1 AT94929998T AT94929998T ATE217309T1 AT E217309 T1 ATE217309 T1 AT E217309T1 AT 94929998 T AT94929998 T AT 94929998T AT 94929998 T AT94929998 T AT 94929998T AT E217309 T1 ATE217309 T1 AT E217309T1
- Authority
- AT
- Austria
- Prior art keywords
- loweralkyl
- amino
- cycloalkyl
- aryl
- nitrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13723693A | 1993-10-14 | 1993-10-14 | |
PCT/US1994/011166 WO1995010519A1 (en) | 1993-10-14 | 1994-09-30 | Quinolizinone type compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE217309T1 true ATE217309T1 (de) | 2002-05-15 |
Family
ID=22476419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94929998T ATE217309T1 (de) | 1993-10-14 | 1994-09-30 | Verbindungen des chinolizinon-typs |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0723545B1 (de) |
JP (1) | JPH09503783A (de) |
KR (1) | KR960704887A (de) |
CN (1) | CN1053188C (de) |
AT (1) | ATE217309T1 (de) |
AU (1) | AU689809B2 (de) |
BR (1) | BR9407806A (de) |
CA (1) | CA2173459A1 (de) |
DE (1) | DE69430581D1 (de) |
IL (1) | IL111185A0 (de) |
WO (1) | WO1995010519A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5726182A (en) * | 1990-05-02 | 1998-03-10 | Abbott Laboratories | Quinolizinone type compounds |
WO1995011902A1 (fr) * | 1993-10-28 | 1995-05-04 | Kaken Pharmaceutical Co., Ltd. | Derive d'acide quinoleine-carboxylique et son sel |
WO1996002512A1 (fr) * | 1994-07-18 | 1996-02-01 | Ube Industries, Ltd. | Acide du type trifluoromethylquinoleinecarboxylique |
AU6181296A (en) * | 1995-04-27 | 1996-11-18 | Kaken Pharmaceutical Co., Ltd. | Optically active quinolinecarboxylic acid derivatives and sa lts thereof |
US5618813A (en) * | 1995-05-26 | 1997-04-08 | Abbott Laboratories | Benzo[5.6]pyrano[2.3.4-ij]quinolizine and benzo[5.6]thiopyrano[2.3.4-ij]quinolizine derivatives as antibacterial and antineoplastic agents |
CA2222322A1 (en) * | 1995-06-06 | 1996-12-12 | Abbott Laboratories | Quinolizinone type compounds |
US5789591A (en) * | 1996-10-23 | 1998-08-04 | Abbott Laboratories | Process for preparing 1-substituted 8-chloro-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid ethyl ester compounds |
US5703244A (en) * | 1996-11-21 | 1997-12-30 | Abbott Laboratories | Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds |
US5693813A (en) * | 1997-02-26 | 1997-12-02 | Abbott Laboratories | Process for preparation of 4H-4-oxo-quinolizine-3-carboxylic acid |
BR9810235A (pt) * | 1997-05-21 | 2001-09-18 | Daiichi Seiyaku Co | Derivados de aminocicloalquil-pirrolidina cis-substituìda |
KR100241673B1 (ko) * | 1997-08-09 | 2000-03-02 | 김충섭 | 퀴놀리진 카르복실산 유도체 |
BR9812644B1 (pt) | 1997-09-15 | 2010-07-13 | quinolonas antimicrobianas, composição farmacêutica e uso das mesmas. | |
US6630488B1 (en) | 1998-09-21 | 2003-10-07 | Biochem Pharma, Inc. | Quinolizinones as integrin inhibitors |
US6197974B1 (en) | 1998-10-26 | 2001-03-06 | Abbott Laboratories | Enantioselective synthesis of 3-aminopyrrolidines |
DE60014143T2 (de) * | 1999-10-19 | 2006-03-02 | Sato Pharmaceutical Co., Ltd. | Antimikrobielle 4-oxochinolizine mit 2-pyridongerüsten als teilstruktur |
WO2002048143A2 (en) | 2000-12-14 | 2002-06-20 | The Procter & Gamble Company | Antimicrobial 2-pyridones, their compositions and uses |
BR0116217A (pt) | 2000-12-14 | 2003-12-30 | Procter & Gamble | Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas |
DOP2002000386A (es) * | 2001-05-30 | 2002-12-15 | Warner Lambert Co | Agentes antibacterianos |
MXPA03010799A (es) | 2001-05-30 | 2005-07-25 | Warner Lambert Co | Agentes antibacterianos. |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
EP2085087A1 (de) | 2001-06-11 | 2009-08-05 | Xenoport, Inc. | Prodrugs aus GABA-Analoga, Zusammensetzungen und ihre Verwendungen |
JP4101754B2 (ja) * | 2001-09-28 | 2008-06-18 | 佐藤製薬株式会社 | 2−ピリドン骨格を部分構造として有する4−オキソキノリジン抗菌剤 |
US6900224B2 (en) * | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
BRPI0406761A (pt) * | 2003-01-14 | 2005-12-20 | Arena Pharm Inc | Derivados de arila e heteroarila 1,2,3-trissubstituìdos como moduladores do metabolismo e a profilaxia e tratamento de distúrbios relacionados a estes tais como diabetes e hiper-glicemia |
AU2004278320B2 (en) * | 2003-09-22 | 2010-06-24 | Janssen Pharmaceutica, N.V. | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
US7977346B2 (en) | 2006-01-17 | 2011-07-12 | Guoqing Paul Chen | Spiro compounds and methods of use |
EP1999125A2 (de) | 2006-03-28 | 2008-12-10 | The Procter and Gamble Company | Kopplungsverfahren zur herstellung von chinolon-zwischenverbindungen |
ATE507219T1 (de) | 2006-03-28 | 2011-05-15 | Warner Chilcott Co Llc | Malatsalze und polymorphe von (3s,5s)-7-ä3-amino- 5-methyl-piperidinylü-1-cyclopropyl-1,4-dihydro 8-methoxy-4-oxo-3-chinolincarbonsäure |
US8278313B2 (en) | 2008-03-11 | 2012-10-02 | Abbott Laboratories | Macrocyclic spiro pyrimidine derivatives |
US8436005B2 (en) | 2008-04-03 | 2013-05-07 | Abbott Laboratories | Macrocyclic pyrimidine derivatives |
CL2009001152A1 (es) * | 2008-05-13 | 2009-10-16 | Array Biopharma Inc | Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa. |
US8691865B2 (en) | 2008-11-26 | 2014-04-08 | Abbvie Inc. | Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers |
WO2011031745A1 (en) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
WO2011149993A2 (en) * | 2010-05-25 | 2011-12-01 | Abbott Laboratories | SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS |
WO2012047487A1 (en) | 2010-09-27 | 2012-04-12 | Evolva Sa | 2-pyridone antimicrobial compositions |
ES2845551T3 (es) * | 2011-02-01 | 2021-07-27 | Emergent Product Dev Gaithersburg Inc | 4-oxoquinolizinas antimicrobianas |
CN105001216B (zh) * | 2015-07-08 | 2017-03-01 | 中国科学院兰州化学物理研究所 | 一种喹嗪酮的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3508816A1 (de) * | 1985-01-10 | 1986-07-10 | Bayer Ag, 5090 Leverkusen | 6,7-disubstituierte 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3-carbonsaeuren |
US4921857A (en) * | 1987-09-18 | 1990-05-01 | Merck & Co., Inc. | 4-Oxo-4h-quinolizine-3-carboxylic acids and derivatives thereof |
IE911472A1 (en) * | 1990-05-02 | 1991-11-06 | Abbott Lab | Quinolizinone type compounds |
-
1994
- 1994-09-30 BR BR9407806A patent/BR9407806A/pt not_active Application Discontinuation
- 1994-09-30 KR KR1019960701906A patent/KR960704887A/ko not_active Application Discontinuation
- 1994-09-30 CN CN94194479A patent/CN1053188C/zh not_active Expired - Fee Related
- 1994-09-30 AT AT94929998T patent/ATE217309T1/de not_active IP Right Cessation
- 1994-09-30 JP JP7511876A patent/JPH09503783A/ja active Pending
- 1994-09-30 CA CA002173459A patent/CA2173459A1/en not_active Abandoned
- 1994-09-30 EP EP94929998A patent/EP0723545B1/de not_active Expired - Lifetime
- 1994-09-30 WO PCT/US1994/011166 patent/WO1995010519A1/en active IP Right Grant
- 1994-09-30 AU AU79258/94A patent/AU689809B2/en not_active Ceased
- 1994-09-30 DE DE69430581T patent/DE69430581D1/de not_active Expired - Lifetime
- 1994-10-06 IL IL11118594A patent/IL111185A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU7925894A (en) | 1995-05-04 |
EP0723545A1 (de) | 1996-07-31 |
DE69430581D1 (de) | 2002-06-13 |
KR960704887A (ko) | 1996-10-09 |
CN1137273A (zh) | 1996-12-04 |
CN1053188C (zh) | 2000-06-07 |
JPH09503783A (ja) | 1997-04-15 |
EP0723545B1 (de) | 2002-05-08 |
WO1995010519A1 (en) | 1995-04-20 |
CA2173459A1 (en) | 1995-04-20 |
IL111185A0 (en) | 1994-12-29 |
BR9407806A (pt) | 1997-08-19 |
AU689809B2 (en) | 1998-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69430581D1 (de) | Verbindungen des chinolizinon-typs | |
MX9709416A (es) | Compuesto tipo quinolizinona. | |
IL96550A0 (en) | Amino acid derivatives,their manufacture and pharmaceutical compositions containing them | |
HU9302329D0 (en) | 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them | |
HU9302330D0 (en) | 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them | |
HUP0100470A2 (hu) | Oxazolidinonszármazékok és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
DE69429591T2 (de) | Therapeutisch wirksame Verbindungen | |
IL105020A0 (en) | Carbapenem derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
WO2002018353A3 (en) | Oxazolidinone chemotherapeutic agents | |
ZA941196B (en) | Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them | |
AP2001002154A0 (en) | Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents. | |
NZ218227A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
HUT45036A (en) | Process for producing new crystalline semi-hydrate of 3-methoxy-4-(4'-amino-benzenesulfonamido)-1,2,5-thiadiazole | |
TH13812A (de) | ||
MY111630A (en) | Amino acid derivatives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |